NMIN
RMC Advisory committees
In addition to the advisory committees below (the HQP Program Advisory Committee and the Commercialization Advisory Board), the RMC also received input from the Executive Committee of the NMIN HQP Network (NHN).
Former HQP Program Advisory Committee
The HQP Program Advisory Committee (HPAC) was an advisory standing committee reporting to the former Research Management Committee (RMC) of NMIN. The HPAC had up to 10 members. The mandate of the HPAC was to advise RMC on training and programming opportunities that will increase the knowledge, skills and expertise of trainees and new professionals in the field of nanomedicine.
CHAIR: Nicolas Bertrand
Associate Professor, Université Laval
Ildiko Badea
Professor, College of Pharmacy and Nutrition University of Saskatchewan
Marianna Foldvari
Professor of Pharmaceutical Sciences, University of Waterloo
Suresh Gadde
Assistant Professor, Faculty of Medicine, University of Ottawa
Azita Haddadi
Associate Professor, College of Pharmacy & Nutrition, University of Saskatchewan
Zeinab Hosseinidoust
Associate Professor, Chemical Engineering, McMaster University
Andrew R. Martin
Associate Professor, Mechanical Engineering, University of Alberta
Naomi Matsuura
Associate Professor, Materials Science & Engineering, University of Toronto
Donald Miller
Professor, Department of Pharmacology & Therapeutics, University of Manitoba
Jennyfer Zapata-Farfan
Chair & President, NHN Executive Committee; Polytechnique Montréal
Former Commercialization Advisory Board
The Commercialization Advisory Board (CAB) provided arm’s-length, expert review and assessment of the funding eligibility of applications to NMIN’s Strategic Initiative (SI) KTEE/Commercialization Support program. It also provided advice and mentorship to NMIN investigators seeking to commercialize their network-supported intellectual property (NSIP).
CHAIR: Brenna Rauw
Founder and Managing Director, 12Bridge
Inès Holzbaur
Co-Founder & Managing Partner, AmorChem
Linh Le
Founder and CEO, Flextrapower Technologies
Helen Loughrey
Health Challenge Officer, National Research Council Canada
CHAIR: Brenna Rauw
Founder and Managing Director, 12Bridge
Stephen Dibert
Strategic Advisor – Life Sciences, Medtech Canada; CEO, TOHealt
Inès Holzbaur
Co-Founder & Managing Partner, AmorChem
Wendy Lamson
Partner and Patent Agent, Perley-Robertson, Hill & McDougall
Paul Santerre
Professor & Baxter Chair in Health Technology & Commercialization (UHN), University of Toronto
Andrew Sinclair
Technology Executive
Gary Skarja
Head of Membrane Chromatography R&D, MilliporeSigma
Helen Loughrey
Health Challenge Officer, National Research Council Canada